For years, the supplement world has been locked in a quiet tug-of-war over vitamin D dosing. Official recommendations from most health agencies have remained conservative, generally suggesting 600 to 800 IU per day for adults. Meanwhile, a growing number of researchers and clinicians have argued that these targets are far too low, especially for people who spend most of their time indoors, live in northern latitudes, or have darker skin.
A major new meta-analysis published in February 2026 in the European Journal of Clinical Nutrition is adding significant weight to the higher-dose camp.
The Study at a Glance
The research team, led by investigators at the University of Copenhagen, pooled data from 42 randomized controlled trials involving over 48,000 participants. The trials ranged from 6 months to 5 years in duration and covered adult populations across North America, Europe, and East Asia.
Their primary question was straightforward: what are the safety and efficacy outcomes of daily vitamin D supplementation at 4,000 IU compared to lower doses and placebo?
Key Findings
Safety was the headline result. Across all 42 trials, daily doses of 4,000 IU did not increase the risk of hypercalcemia, kidney stones, or vascular calcification compared to placebo or lower-dose groups. The incidence of adverse events was statistically identical between groups.
This matters because the 4,000 IU mark has long been set as the “tolerable upper intake level” by the Institute of Medicine, a ceiling that many clinicians have treated as a warning rather than a guideline. This meta-analysis suggests that 4,000 IU is not a danger threshold but a well-tolerated daily dose for the general adult population.
Beyond safety, the efficacy data was encouraging. Participants supplementing at 4,000 IU daily showed:
- 25(OH)D blood levels consistently above 40 ng/mL, a range that many researchers consider optimal, compared to the 20 ng/mL floor used in current guidelines.
- A 14% reduction in respiratory infections across trials that tracked this outcome, consistent with previous findings from the VITAL and D-Health studies.
- Modest but significant improvements in mood scores in trials that measured depressive symptoms, particularly in participants who were deficient at baseline.
- No additional benefit for cardiovascular events or cancer incidence at the population level, though subgroup analyses hinted at possible benefits in severely deficient individuals.
What This Means for Your Supplement Routine
This study does not mean everyone should immediately start taking 4,000 IU of vitamin D daily. Individual needs vary based on baseline levels, body weight, skin pigmentation, sun exposure, and health status. What it does mean is that the evidence base for this dose level is now substantially stronger, and the safety concerns that have kept many practitioners cautious appear to be unfounded for most healthy adults.
If you are currently taking 1,000 to 2,000 IU daily and your blood levels remain below 30 ng/mL, this research supports a conversation with your healthcare provider about increasing your dose.
The Vitamin K2 Connection
One practical note that the meta-analysis authors emphasized: higher vitamin D intake increases calcium absorption, which makes vitamin K2 a sensible companion supplement. Vitamin K2, particularly the MK-7 form, directs calcium toward bones and teeth and away from soft tissues and arteries. If you are increasing your vitamin D dose, adding 100 to 200 mcg of vitamin K2 (MK-7) is a well-supported precaution.
The Bottom Line
The gap between what official guidelines recommend and what the research supports has been widening for years. This 2026 meta-analysis narrows that gap considerably by providing large-scale evidence that 4,000 IU daily is both safe and potentially beneficial for most adults.
The science is not settled, and individual testing remains the gold standard for personalizing your dose. But if you have been hesitant about higher vitamin D supplementation, the evidence in its favor has never been more robust.